
|Videos|October 23, 2021
Study examines association between finasteride and suicidality, depression, and anxiety
Author(s)Urology Times staff
“What we wanted to do was to substantiate any difference between BPH and alopecia with finasteride and also people who are concomitantly taking testosterone for hypogonadism,” says Kevin J. Campbell, MD, MS.
Advertisement
In this video, Kevin J. Campbell, MD, MS, discusses the background and findings of the study, “Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence,” presented recently at the 2021 Sexual Medicine Society of North America Fall Scientific Meeting. Campbell is an assistant professor in the department of urology at the University of Florida, Gainesville.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
3
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
4
Interpreting PSMA PET Imaging in Prostate Cancer
5






